[[STAGE]] Meaningful clinical benefit: Optimal endpoints for ABC clinical trials: Can we aim for more? (ABC5)

Meaningful clinical benefit: Optimal endpoints for ABC clinical trials: Can we aim for more? (ABC5)

E-session 504010

For further information about the event click here

ESO-ESMO Advanced Breast Cancer Fifth International Consensus Conference (ABC5) 14.11.2019 - 16.11.2019 Lisbon, Portugal
For further information about the event click here

Expert

Nadia Harbeck

Breast Center, LMU University Hospital
Munich, Germany

Nov 2019

ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.

Ulm university

The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de

The mastermind winners of
e-Session 660

Reda Mohamed Husseen
Marina Puchinskaya
Zacharoula Sidiropoulou

ESO & OncoAlert

Oncology education together via social media

Meaningful clinical benefit: Optimal endpoints for ABC clinical trials: Can we aim for more? (ABC5)

Share on:

Related e-Sessions:

Ulm university

The mastermind winners of e-Session 660

ESO & OncoAlert

The mastermind winners of
e-Session 660